The situation
Scientia Vascular had developed a novel neurovascular access platform and was entering a rapidly evolving competitive landscape. As new technologies emerged and incumbents adjusted their positioning, leadership needed to ensure the company's commercial story could support long-term category relevance—not just near-term momentum.
The challenge was not awareness or design execution.
It was determining how the company should show up as the category evolved.
What was unclear
While the technology was strong, the team lacked clarity on:
- How to differentiate meaningfully across distinct stakeholder groups, including surgeons, hospital systems, and channel partners
- Which elements of the story needed to remain consistent—and where flexibility was appropriate
- How to avoid over-rotating on technical detail at the expense of strategic positioning
Without this clarity, scaling commercial efforts risked creating internal misalignment and external confusion.
What changed
Through structured diagnostic work, RŌG Health helped leadership pressure-test assumptions about differentiation, buyer logic, and narrative sequencing.
Rather than starting with execution, the work focused on defining:
- The company's true point of distinction in the context of emerging competitors
- A clear narrative hierarchy that could adapt across buyer contexts without losing coherence
- Guardrails for future messaging as the product portfolio and market footprint expanded
This created a shared, defensible view of how Scientia Vascular should compete—not just what it should say.
How RŌG Health was involved
RŌG Health supported leadership clarity around positioning, buyer logic, and sequencing—ensuring that future commercial decisions were grounded in a coherent strategic foundation before execution scaled.
As clarity solidified, we continued to support Scientia Vascular through execution—serving as an ongoing strategic and creative partner as the company brought its narrative to market across key channels.
Following the diagnostic work, RŌG Health became Scientia Vascular's agency of record, supporting ongoing execution in alignment with the established strategic framework.
Resulting direction
With a clear narrative framework in place, Scientia Vascular was able to move forward confidently—aligning leadership, supporting commercial planning, and enabling more disciplined decisions around partnerships, sales expansion, and investor communication.
Execution followed clarity—not the other way around—allowing the company to scale its presence without diluting its strategic position.
The outcome wasn't a campaign.
It was clarity leadership could operate from.